News | September 11, 2024
Evonik starts operation of new spray drying facility for pharmaceutical oral excipients
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
The new facility further improves the operational efficiency and readies the site for the completion of the new large-scale production plant
The company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector
The grant is designated for the research and development of Pyronaridine
This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
India Business grew by 11.9% YoY to Rs. 1196.2 crore
Majority of organizations are looking to increase investments in public and hybrid cloud
Gross profit was Rs. 328.8 crore, up by 27.8% YoY with a gross margin expansion of 418 bps to 55.7%
Revenue up 16.3% to Rs 5,600 crore versus Rs 4,814 crore
Subscribe To Our Newsletter & Stay Updated
